Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine : A Proof-of-Concept Study
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:175 |
|---|---|
| Enthalten in: |
Annals of internal medicine - 175(2022), 12 vom: 28. Dez., Seite 1771-1774 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Roozen, Geert V T [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2019-nCoV Vaccine mRNA-1273 |
|---|
| Anmerkungen: |
Date Completed 21.12.2022 Date Revised 03.01.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.7326/M22-2089 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347941230 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347941230 | ||
| 003 | DE-627 | ||
| 005 | 20231226035023.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7326/M22-2089 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1159.xml |
| 035 | |a (DE-627)NLM347941230 | ||
| 035 | |a (NLM)36279543 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Roozen, Geert V T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine |b A Proof-of-Concept Study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.12.2022 | ||
| 500 | |a Date Revised 03.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a 2019-nCoV Vaccine mRNA-1273 |2 NLM | |
| 650 | 7 | |a EPK39PL4R4 |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 650 | 7 | |a Influenza Vaccines |2 NLM | |
| 700 | 1 | |a Prins, Margaretha L M |e verfasserin |4 aut | |
| 700 | 1 | |a van Binnendijk, Rob |e verfasserin |4 aut | |
| 700 | 1 | |a den Hartog, Gerco |e verfasserin |4 aut | |
| 700 | 1 | |a Kuiper, Vincent P |e verfasserin |4 aut | |
| 700 | 1 | |a Prins, Corine |e verfasserin |4 aut | |
| 700 | 1 | |a Janse, Jacqueline J |e verfasserin |4 aut | |
| 700 | 1 | |a Kruithof, Annelieke C |e verfasserin |4 aut | |
| 700 | 1 | |a Feltkamp, Mariet C W |e verfasserin |4 aut | |
| 700 | 1 | |a Kuijer, Marjan |e verfasserin |4 aut | |
| 700 | 1 | |a Rosendaal, Frits R |e verfasserin |4 aut | |
| 700 | 1 | |a Roestenberg, Meta |e verfasserin |4 aut | |
| 700 | 1 | |a Visser, Leo G |e verfasserin |4 aut | |
| 700 | 1 | |a Roukens, Anna H E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of internal medicine |d 1945 |g 175(2022), 12 vom: 28. Dez., Seite 1771-1774 |w (DE-627)NLM000012777 |x 1539-3704 |7 nnns |
| 773 | 1 | 8 | |g volume:175 |g year:2022 |g number:12 |g day:28 |g month:12 |g pages:1771-1774 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7326/M22-2089 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 175 |j 2022 |e 12 |b 28 |c 12 |h 1771-1774 | ||